These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23407292)

  • 1. Conservative management of bilateral vestibular schwannomas in neurofibromatosis type 2 patients: hearing and tumor growth results.
    Peyre M; Goutagny S; Bah A; Bernardeschi D; Larroque B; Sterkers O; Kalamarides M
    Neurosurgery; 2013 Jun; 72(6):907-13; discussion 914; quiz 914. PubMed ID: 23407292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consequences to hearing during the conservative management of vestibular schwannomas.
    Walsh RM; Bath AP; Bance ML; Keller A; Rutka JA
    Laryngoscope; 2000 Feb; 110(2 Pt 1):250-5. PubMed ID: 10680925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance of bilateral vestibular schwannoma growth and hearing changes in neurofibromatosis 2: neurofibromatosis 2 natural history consortium.
    Fisher LM; Doherty JK; Lev MH; Slattery WH
    Otol Neurotol; 2009 Sep; 30(6):835-41. PubMed ID: 19704365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear accelerator-based stereotactic radiosurgery for bilateral vestibular schwannomas in patients with neurofibromatosis type 2.
    Meijer OW; Vandertop WP; Lagerwaard FJ; Slotman BJ
    Neurosurgery; 2008 May; 62(5 Suppl):A37-42; discussion A42-3. PubMed ID: 18580779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management of vestibular schwannomas and hearing rehabilitation in neurofibromatosis type 2.
    Tysome JR; Macfarlane R; Durie-Gair J; Donnelly N; Mannion R; Knight R; Harris F; Vanat ZH; Tam YC; Burton K; Hensiek A; Raymond FL; Moffat DA; Axon PR
    Otol Neurotol; 2012 Apr; 33(3):466-72. PubMed ID: 22334163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosurgical treatment of vestibular schwannomas in patients with neurofibromatosis type 2: tumor control and hearing preservation.
    Phi JH; Kim DG; Chung HT; Lee J; Paek SH; Jung HW
    Cancer; 2009 Jan; 115(2):390-8. PubMed ID: 19109818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery for neurofibromatosis 2-associated vestibular schwannomas: toward dose optimization for tumor control and functional outcomes.
    Mallory GW; Pollock BE; Foote RL; Carlson ML; Driscoll CL; Link MJ
    Neurosurgery; 2014 Mar; 74(3):292-300; discussion 300-1. PubMed ID: 24335819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hearing preservation with the middle cranial fossa approach for neurofibromatosis type 2.
    Friedman RA; Goddard JC; Wilkinson EP; Schwartz MS; Slattery WH; Fayad JN; Brackmann DE
    Otol Neurotol; 2011 Dec; 32(9):1530-7. PubMed ID: 21986931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of hearing preservation in untreated vestibular schwannomas.
    Sughrue ME; Kane AJ; Kaur R; Barry JJ; Rutkowski MJ; Pitts LH; Cheung SW; Parsa AT
    J Neurosurg; 2011 Feb; 114(2):381-5. PubMed ID: 20486891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle fossa decompression for hearing preservation: a review of institutional results and indications.
    Slattery WH; Hoa M; Bonne N; Friedman RA; Schwartz MS; Fisher LM; Brackmann DE
    Otol Neurotol; 2011 Aug; 32(6):1017-24. PubMed ID: 21725256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of untreated vestibular schwannomas. Is there a role for conservative management?
    Walsh RM; Bath AP; Bance ML; Keller A; Tator CH; Rutka JA
    Rev Laryngol Otol Rhinol (Bord); 2000; 121(1):21-6. PubMed ID: 10865479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vestibular schwannoma: role of conservative management.
    Suryanarayanan R; Ramsden RT; Saeed SR; Aggarwal R; King AT; Rutherford SA; Evans DG; Gillespie JE
    J Laryngol Otol; 2010 Mar; 124(3):251-7. PubMed ID: 20003606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hearing outcome after gamma knife radiosurgery for vestibular schwannoma: a prospective Belgian clinical study.
    Delbrouck C; Hassid S; Choufani G; De Witte O; Devriendt D; Massager N
    B-ENT; 2011; 7 Suppl 17():77-84. PubMed ID: 22338378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cochlear implants to treat deafness caused by vestibular schwannomas.
    Mukherjee P; Ramsden JD; Donnelly N; Axon P; Saeed S; Fagan P; Irving RM
    Otol Neurotol; 2013 Sep; 34(7):1291-8. PubMed ID: 23921933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acoustic neuromas and serviceable hearing: choosing the surgical approach].
    Bozorg-Grayeli A; Kalamarides M; Tormin-Borges-Crosara PF; Bouccara D; Rey A; Sterkers O
    Neurochirurgie; 2002 Dec; 48(6):479-86. PubMed ID: 12595803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of large vestibular schwannomas in patients with neurofibromatosis type 2: outcomes on facial nerve function and hearing preservation.
    Zhao F; Wang B; Yang Z; Zhou Q; Li P; Wang X; Zhang J; Zhang J; Liu P
    J Neurooncol; 2018 Jun; 138(2):417-424. PubMed ID: 29492767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
    Plotkin SR; Merker VL; Halpin C; Jennings D; McKenna MJ; Harris GJ; Barker FG
    Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric neurofibromatosis type 2: clinical and molecular presentation, management of vestibular schwannomas, and hearing rehabilitation.
    Bonne N-; Aboukais R; Baroncini M; Hochart A; Leblond P; Broly F; Dubrulle F; Lejeune JP; Vincent C
    Childs Nerv Syst; 2016 Dec; 32(12):2403-2413. PubMed ID: 27704245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of hearing in vestibular schwannomas treated by radiosurgery using Leksell Gamma Knife: preliminary report of a prospective Belgian clinical study.
    Delbrouck C; Hassid S; Massager N; Choufani G; David P; Devriendt D; Levivier M
    Acta Otorhinolaryngol Belg; 2003; 57(3):197-204. PubMed ID: 14571654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochlear implantation in patients with neurofibromatosis type 2 and bilateral vestibular schwannoma.
    Lustig LR; Yeagle J; Driscoll CL; Blevins N; Francis H; Niparko JK
    Otol Neurotol; 2006 Jun; 27(4):512-8. PubMed ID: 16791043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.